| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO
PL PT RO SE SI SK SM TR |
|
Designated Extension States: |
|
AL BA RS |
| (30) |
Priority: |
23.12.2008 US 203569 P
25.11.2009 US 264622 P
|
| (43) |
Date of publication of application: |
|
28.06.2017 Bulletin 2017/26 |
| (60) |
Divisional application: |
|
19181187.6 |
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
09775072.3 / 2379594 |
| (73) |
Proprietor: Amgen Inc. |
|
Thousand Oaks, California 91320-1799 (US) |
|
| (72) |
Inventors: |
|
- BOONE, Thomas Charles
Newbury Park CA 91320 (US)
- BRANKOW, David W.
Northridge CA 91326 (US)
- GEGG, Colin V., Jr.
Camarillo, CA 93012 (US)
- HU, Shaw-Fen Sylvia
Thousand Oaks, CA 91360 (US)
- King, Chadwick T.
Noreth Vancouver, BC V7L 3T5 (CA)
- LU, Hsieng Sen
Thousand Oaks, CA 91362 (US)
- SHI, Licheng
Newbury Park, CA 91320 (US)
- XU, Cen
Newbury Park, CA 91320 (US)
|
| (74) |
Representative: Grünecker Patent- und Rechtsanwälte
PartG mbB |
|
Leopoldstraße 4
80802 München
80802 München (DE) |
| (56) |
References cited: :
|
| |
|
|
- MCLATCHIE L M ET AL: "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like
receptor.", NATURE 28 MAY 1998, vol. 393, no. 6683, 28 May 1998 (1998-05-28), pages
333-339, XP002767658, ISSN: 0028-0836
- Committee on Methods of Producing MonoclonalAntibodies, Institute for Laboratory Animal
Research,National Research Council: "Monoclonal Antibody Production", 1999, National
Academy Press, Washington, DC, XP002767659, ISBN: 0-309-51904-7 * page 10 *
- TAYLOR CHRISTOPHER K ET AL: "PHARMACOLOGICAL CHARACTERIZATION OF NOVEL ALPHA-CALCITONIN
GENE-RELATED PEPTIDE (CGRP) RECEPTOR PEPTIDE ANTAGONISTS THAT ARE SELECTIVE FOR HUMAN
CGRP RECEPTORS", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY
FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 319, no. 2, 1 November 2006
(2006-11-01), pages 749-757, XP009084228, ISSN: 0022-3565
- DAVIS CARL D ET AL: "The Tortuous Road to an Ideal CGRP Function Blocker for the Treatment
of Migraine", CURRENT TOPICS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS LTD,
NL, vol. 8, no. 16, 1 November 2008 (2008-11-01), pages 1468-1479, XP008119816, ISSN:
1568-0266
- CHAUHAN M ET AL: "Studies on the effects of the N-terminal domain antibodies of calcitonin
receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related
peptide-induced vasorelaxation in rat uterine artery.", June 2004 (2004-06), BIOLOGY
OF REPRODUCTION JUN 2004, VOL. 70, NR. 6, PAGE(S) 1658 - 1663, XP002571487, ISSN:
0006-3363 * the whole document *
- DURHAM PAUL L: "CGRP-RECEPTOR ANTAGONISTS--A FRESH APPROACH TO MIGRAINE THERAPY?",
NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol.
350, no. 11, 11 March 2004 (2004-03-11), pages 1073-1075, XP009082423, ISSN: 1533-4406
- TEPPER STEWART ET AL: "Safety and efficacy of erenumab for preventive treatment of
chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial", LANCET
NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 16, no. 6, 28 April 2017 (2017-04-28)
, pages 425-434, XP085003376, ISSN: 1474-4422, DOI: 10.1016/S1474-4422(17)30083-2
|
|
